MGX Revenue FlowMGX Graph summaryMetagenomi Therapeutics, Inc. (MGX). Quarter ended 2026-03-31. Reported revenue sources, expenses and earnings; undisclosed amounts are not inferred.How Metagenomi Therapeutics, Inc. made money in the latest quarterLatest-quarter revenue sources flow through cost of revenue, gross profit, operating expenses, tax, and net income. $0.00B $0.03B$-0.02B$0.02B$0.01B$-0.02B$0.00B$0.00B$-0.02B Revenue from contracts with customers, excluding assessed tax$0.00BDeclared revenue$0.00B Operating expenses$0.03BOperating income$-0.02BResearch and development$0.02BGeneral and administrative$0.01BOther income, net$0.00BPre-tax income$-0.02BIncome tax$0.00BNet income$-0.02BComplete revenue composition table
MGX Revenue FlowMGX Graph summaryMetagenomi Therapeutics, Inc. (MGX). Quarter ended 2026-03-31. Reported revenue sources, expenses and earnings; undisclosed amounts are not inferred.How Metagenomi Therapeutics, Inc. made money in the latest quarterLatest-quarter revenue sources flow through cost of revenue, gross profit, operating expenses, tax, and net income. $0.00B $0.03B$-0.02B$0.02B$0.01B$-0.02B$0.00B$0.00B$-0.02B Revenue from contracts with customers, excluding assessed tax$0.00BDeclared revenue$0.00B Operating expenses$0.03BOperating income$-0.02BResearch and development$0.02BGeneral and administrative$0.01BOther income, net$0.00BPre-tax income$-0.02BIncome tax$0.00BNet income$-0.02BComplete revenue composition table